Shaimaa Said

Shaimaa Said is a Senior Regulatory Affairs Specialist with extensive experience in the pharmaceutical and medical device sectors. Currently employed at Baxter International Inc. since February 2023, Shaimaa focuses on Human Pharma and MD Registration along with EU MDR implementation. Concurrently, Shaimaa serves in a similar role at the Egyptian Drug Authority, acting as the WHO GBT Marketing Authorization focal point and overseeing the registration of human pharmaceuticals. Previous positions include significant regulatory roles at Bayer and the Central Administration for Pharmaceutical Affairs. Shaimaa's career began as a Hospital Pharmacist and Community Pharmacist, bolstered by academic qualifications, including an MBA in Strategic Management from the Arab Academy for Science, Technology and Maritime Transport and a Bachelor of Pharmacy from Future University in Egypt.